Frances Hamilton Arnold
Independent DirectorDr. Frances Hamilton Arnold, Ph.D., serves as an Independent Director at Alphabet Inc. since December 7, 2019. Dr. Arnold also serves as an Independent Director of Generate Biomedicines since July 2019, a Venture Partner of Catalio Capital Management, LP, a Member of Growth Technical Advisory Board at Applied Materials, Inc., a Director at Altos Labs, Inc., a Director at Google LLC, a Member of Scientific and Clinical Advisory Board at Iambic Therapeutics, Inc. and on the Scientific Advisory Board at Twist Biosciences and Entos. She serves on the Board of Directors of Alphabet, Illumina and Provivi and as a Member of Scientific Advisory Board of Mascoma Corporation and Entos, Inc. Dr. Arnold serves as a Director of Provivi, Inc. She has been appointed co-chair of the President’s Council of Advisors on Science and Technology by President Biden. Dr. Arnold has been the Dick and Barbara Dickinson Professor of Chemical Engineering and Biochemistry at the California Institute of Technology since 1986, where she also served as a Visiting Associate, Assistant Professor, Professor and Director. She is the Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry and a Director of the Donna and Benjamin M. Rosen Bioengineering Center at the California Institute of Technology. Dr. Arnold was an Independent Director of Illumina Inc. since January 28, 2016 until May 21, 2026. She is a Member of the National Academy of Engineering, the National Academy of Sciences and the Institute of Medicine and a Fellow at the American Institute for Medical and Biological Engineering. She has been elected to membership in all three US National Academies, of Science, Medicine and Engineering. Dr. Arnold focuses on directed evolution, biocatalysis and protein engineering. She is involved in alternative energy research, including the development of highly active enzymes and microorganisms to convert renewable biomass to fuels and chemicals and explores new biology-based approaches to production of fuels and chemicals. She is a pioneer of directed evolution and is Inventor or Co-inventor on more than 20 patents. Dr. Arnold was awarded the Nobel Prize in Chemistry in 2018 for pioneering directed enzyme evolution. She is the recipient of numerous honors, including induction into the National Inventors Hall of Fame (2014), Fellow of the National Academy of Inventors (2014), the ENI Prize in Renewable and Nonconventional Energy (2013), the Charles Stark Draper Prize (2011), the National Medal of Technology and Innovation (2011), Member, American Academy of Arts and Sciences (2011), Fellow, American Association for the Advancement of Science (2010) and Fellow, American Academy of Microbiology (2009). Previously, Dr. Arnold was a Research Fellow at the Department of Chemistry at the University of California, Berkeley. She served as a Member of Advisory Board at Fluidigm Corporation since August 1999. Dr. Arnold Co-founded Gevo, Inc. in 2005 and served as its Consultant. She served as a Director of Gevo, Inc. until June 24, 2010. She served as a Member of Advisory Board of Gevo, Inc. and Arzeda Corporation. Dr. Arnold served as a Member of Scientific Advisory Board of Amyris, Inc. and as a Member of Advisory Board of Codexis, Inc. She served as an Influential Advisor to Maxygen and several other directed evolution companies. She has been a Member of Scientific Advisory Board at Genomatica, Inc. since May 2013. Dr. Arnold served as a Member of Scientific Advisory Board of Conagen, Inc. until April 2020. She was Director of National Resilience, LLC until 2026. Dr. Arnold holds a Bachelor of Science in Mechanical and Aerospace Engineering from Princeton University in 1979 and a Doctoral degree in Chemical Engineering from the University of California, Berkeley in 1985.
公司职务
- 公司名称Generate Biomedicines, Inc.股票代码GENB职务Independent Director
